[Use of a new combination: Trimethoprim-Sulfamethoxasole in urinary infections in gynecology-obstetrics].
D000890:Anti-Infective Agents / Q000627:therapeutic use*; D004338:Drug Combinations; D005260:Female; D005493:Folic Acid Antagonists / Q000627:therapeutic use*; D006801:Humans; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy*; D011645:Puerperal Infection / Q000188:drug therapy*; D011743:Pyrimidines / Q000627:therapeutic use*; D013420:Sulfamethoxazole / Q000009:adverse effects / Q000627:therapeutic use*; D014295:Trimethoprim / Q000009:adverse effects / Q000627:therapeutic use; D014552:Urinary Tract Infections / Q000188:drug therapy*
D000890:Anti-Infective Agents; D004338:Drug Combinations; D005493:Folic Acid Antagonists; D011743:Pyrimidines; D014295:Trimethoprim; D013420:Sulfamethoxazole
Utilisation d'une nouvelle association Triméthoprime-Sulfaméthoxasole dans les infections urinaires en gynécologie-obstétrique.